Tiny camera vs. standard scope: which ACL surgery costs less?
NCT ID NCT07553975
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will compare the costs and patient satisfaction of ACL knee surgery using a smaller, newer camera system (NanoScope) versus the traditional arthroscopy method. About 42 adults aged 18-60 with an ACL tear will be randomly assigned to one of the two surgical approaches. The goal is to see if the NanoScope can reduce operating room costs while maintaining or improving patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 42 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subject is 18 - 60 years of age. * Subject body mass index (BMI) is 40 or lower (BMI ≤ 40). * Subject signed informed consent and is willing and able to comply with all study requirements and follow-up visits. * Confirmed ACL injury by MRI and physical exam as per standard of care. * Subjects not excluded for having meniscal pathology that requires resection or repair. * Subjects not excluded for having lateral-extra-articular tenodesis Exclusion Criteria: * Revision ACL case. * Current bilateral knee injury. * Insufficient quantity or quality of bone. * Blood supply limitations and previous infections which may retard healing. * Subjects that are skeletally immature. * Advanced Osteoarthritis; Kellgren Lawrence ≥ 2 * Fracture of the lower extremities within 6 months prior to screening. * Previous surgery on the affected knee within 12 months related to the ACL reconstruction, prior to screening. * Sensitivity to silicone, polyester, nylon, FD\&C Blue No. 2 dye and beeswax. * Other concomitant disease that would interfere with study outcomes. * Subject is included in a vulnerable population (child, prisoner, etc.). * Conditions that tend to limit the patient's ability or willingness to restrict activities, follow directions, or perform online subject assessments during the healing period. * Subject is requesting or receiving Worker's compensation related to the knee injury.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anterior cruciate ligament are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.